10-09 :: September 2010
nanotimes News in Brief
55
“Everyone said you can‘t use arsenic for solid tumors,” said O‘Halloran, also associate director of basic sci- ences at the Lurie Cancer Center. “That‘s because they didn‘t deliver it the right way. This new technology delivered the drug directly to the tumor, maintained its stability and shielded normal cells from the toxicity. That‘s huge.”
The nanoparticle technology has great potential for other existing cancer drugs that have been shelved be- cause they are too toxic or excreted too rapidly, Cryns noted. “We can potentially make those drugs more effective against solid tumors by increasing their delivery to the tumor and by shielding normal cells from their toxicity,” he said. “This nanotechnology platform has the potential to expand our arsenal of chemotherapy drugs to treat cancer.”
Richard W. Ahn, Feng Chen, Haimei Chen, Stephan T. Stern, Jeffrey D. Clogston, Anil K. Patri, Meera R. Raja, Elden P. Swin- dell, Vamsi Parimi, Vincent L. Cryns, and Thomas V. O‘Halloran: A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer, In: Clinical Cancer Research, Vol. 16 (2010), No. 14, July 15, 2010, Pages 3607-3617, DOI:10.1158/
1078-0432.CCR-10-0068:
http://dx.doi.org/10.1158/1078-0432.CCR-10-0068
Transmission electron micrograph shows 100 nm lipid vesicles that contain a highly concentrated complex of arsenic trioxide (> 270 mmol/L). This nanoparticulate formulation (termed “nanobin”) markedly improves the pharmacokinetics of the cytotoxic agent, resulting in enhanced antitumor efficacy in a murine model of breast cancer. Nanobin encapsulation of arsenic trioxide may increase its therapeutic utility in breast cancer and potentially other solid tumors. © Clinical Cancer Research
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81